Page last updated: 2024-08-24

irinotecan and Mesothelioma

irinotecan has been researched along with Mesothelioma in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (5.00)	18.2507
2000's	13 (65.00)	29.6817
2010's	4 (20.00)	24.3611
2020's	2 (10.00)	2.80

Authors

Authors	Studies
Aigner, C; Bankfalvi, A; Hegedüs, B; Hegedüs, L; Mairinger, F; Okumus, Ö; Ploenes, T; Reuter, S; Schuler, M; Theegarten, D; Vega-Rubin-de-Celis, S; Welt, A	1
Han, B; Hino, O; Ishimine, M; Kajino, K; Kobayashi, T; Lee-Okada, HC; Nishikawa, K; Orita, H; Takagaki, T; Yokomizo, T	1
Andre, T; Aoun, O; Delhorme, JB; Eveno, C; Ferron, G; Gayat, E; Goéré, D; Lo Dico, R; Malgras, B; Marchal, F; Passot, G; Pautrat, K; Pocard, M; Sgarbura, O	1
Bakrin, N; Cotte, E; Gilly, FN; Glehen, O; Passot, G; Roux, AS; Vaudoyer, D	1
Fukita, S; Saitoh, M; Takeda, S; Takeda, T	1
Dartigues, P	1
Betta, PG; Catalano, A; Lazzarini, R; Moretti, S; Orecchia, S; Procopio, A	1
Ardizzoni, A; de Cupis, A; Favoni, RE; Loprevite, M; Pirani, P; Semino, C	1
Deavers, M; Hunt, K; Le, DT; Malpica, A; Verschraegen, CF	1
Dhaliwal, K; Evans, MT; Fennell, DA; Gower, N; Parmar, A; Rudd, R; Shamash, J; Sheaff, MT; Steele, J; Sylvester, R	1
Catassi, A; Cesario, A; Ferri, L; Festi, L; Granone, P; Malacarne, D; Margaritora, S; Mulé, A; Russo, P	1
Green, MR; Herndon, JE; Kindler, HL; Zhang, C	1
Nakano, T	1
Evans, MT; Fennell, DA; Rudd, RM; Shamash, J; Sheaff, MT; Stebbing, J; Steele, JP; Wells, P	1
Sugarbaker, PH	1
Bedard, V; Bouzid, T; Duvillard, P; Elias, D; Goere, D; Kohneh-Sharhi, N; Raynard, B	1
Chahinian, AP; Higashino, K; Miyake, M; Nakano, T; Ninomiya, K; Shinjo, M; Togawa, N; Tonomura, A; Yamamoto, T	1
Jekunen, A; Knuuttila, A; Linnainmaa, K; Mattson, K; Ollikainen, T; Suhonen, S; Taavitsainen, M	1
Lake, RA; McLaren, BR; Robinson, BW	1
Halme, M; Jekunen, A; Kivisaari, L; Knuuttila, A; Linnainmaa, K; Mali, P; Mattson, K; Ollikainen, T	1

Reviews

2 review(s) available for irinotecan and Mesothelioma

Article	Year
[Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma]. Annales de pathologie, 2015, Volume: 35, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carboplatin; Combined Modality Therapy; Cystadenofibroma; Diagnosis, Differential; Female; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Parenteral; Irinotecan; Leucovorin; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Oxaliplatin; Paclitaxel; Pemetrexed; Peritoneal Neoplasms	2015
[Malignant mesothelioma--diagnosis and treatment strategies]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Asbestos; Camptothecin; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Interleukin-6; Irinotecan; Mediastinal Neoplasms; Mesothelioma; Pleural Neoplasms; Tomography, X-Ray Computed	2006

Article

Year

[Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma].

Annales de pathologie, 2015, Volume: 35, Issue:4

Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carboplatin; Combined Modality Therapy; Cystadenofibroma; Diagnosis, Differential; Female; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Parenteral; Irinotecan; Leucovorin; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Oxaliplatin; Paclitaxel; Pemetrexed; Peritoneal Neoplasms

2015

[Malignant mesothelioma--diagnosis and treatment strategies].

Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:9

Topics: Antineoplastic Combined Chemotherapy Protocols; Asbestos; Camptothecin; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Interleukin-6; Irinotecan; Mediastinal Neoplasms; Mesothelioma; Pleural Neoplasms; Tomography, X-Ray Computed

2006

Trials

4 trial(s) available for irinotecan and Mesothelioma

Article	Year
Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer investigation, 2003, Volume: 21, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Irinotecan; Male; Mesothelioma; Middle Aged; Peritoneal Neoplasms; Retrospective Studies	2003
Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. Lung cancer (Amsterdam, Netherlands), 2005, Volume: 48, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Disease Progression; Female; Heart Neoplasms; Humans; Infusions, Intravenous; Irinotecan; Mesothelioma; Middle Aged; Peritoneal Neoplasms; Pleural Neoplasms; Survival Analysis; Treatment Outcome	2005
Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma: a pilot phase II clinical trial and pharmacokinetic profile. Cancer, 1999, Jun-01, Volume: 85, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Female; Humans; Injections, Intravenous; Irinotecan; Male; Mesothelioma; Middle Aged; Pilot Projects; Pleural Diseases	1999
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study. Anti-cancer drugs, 2000, Volume: 11, Issue:4 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Feasibility Studies; Female; Humans; Irinotecan; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Pleural Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2000

Other Studies

14 other study(ies) available for irinotecan and Mesothelioma

Article	Year
TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy. Lung cancer (Amsterdam, Netherlands), 2023, Volume: 178 Topics: Cell Line, Tumor; Humans; Immunoconjugates; Irinotecan; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; RNA	2023
Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells. FEBS open bio, 2020, Volume: 10, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboxylesterase; Cell Death; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Irinotecan; Mesothelioma; Mutagens; Piperazines; Tumor Suppressor Protein p53	2020
Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study. Annals of surgical oncology, 2018, Volume: 25, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Doxorubicin; Erythrocyte Transfusion; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Irinotecan; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Mitomycin; Oxaliplatin; Peritoneal Neoplasms; Prognosis; Prospective Studies; Survival Rate	2018
Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Cisplatin; Cohort Studies; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Irinotecan; Male; Mesothelioma; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Peritoneal Neoplasms; Peritoneum; Prospective Studies; Pseudomyxoma Peritonei; Quality of Life; Stomach Neoplasms; Treatment Outcome	2014
Small cell carcinoma presenting with massive pleural spread mimicking malignant pleural mesothelioma. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:6 Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Cisplatin; Diagnosis, Differential; Fatal Outcome; Humans; Irinotecan; Male; Mesothelioma; Neoplasm Recurrence, Local; Pleural Effusion, Malignant; Pleural Neoplasms; Small Cell Lung Carcinoma	2014
Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Aug-15, Volume: 14, Issue:16 Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Immunoblotting; In Situ Nick-End Labeling; Irinotecan; Male; Mesothelioma; Mice; Mice, Nude; RNA Interference; Transfection; Xenograft Model Antitumor Assays	2008
Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines. European journal of pharmacology, 2003, Jul-25, Volume: 473, Issue:2-3 Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cell Division; Cell Line; Cisplatin; Deoxycytidine; DNA, Neoplasm; Docetaxel; Drug Screening Assays, Antitumor; Fenretinide; Flow Cytometry; Gemcitabine; Humans; Irinotecan; Mesothelioma; Paclitaxel; Taxoids; Topotecan	2003
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-01, Volume: 23, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Logistic Models; Male; Mesothelioma; Middle Aged; Mitomycin; Models, Theoretical; Organoplatinum Compounds; Oxaliplatin; Pleural Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Vinblastine; Vinorelbine	2005
Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells: the role of nuclear factor-kappaB pathway activation. Cancer, 2005, Apr-01, Volume: 103, Issue:7 Topics: Apoptosis; bcl-X Protein; Camptothecin; Caspases; Cell Cycle; Cell Survival; Cytochromes c; DNA Damage; DNA Fragmentation; Drug Synergism; Humans; Irinotecan; Mesothelioma; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Necrosis Factors	2005
Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma. Cancer, 2007, Jan-01, Volume: 109, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Female; Humans; Irinotecan; Male; Mesothelioma; Middle Aged; Mitomycin; Pleural Neoplasms; Quality of Life; Survival Rate; Treatment Outcome	2007
Local-regional approach to diffuse malignant peritoneal mesothelioma. Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:10 Topics: Antineoplastic Agents; Camptothecin; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Humans; Hyperthermia, Induced; Irinotecan; Mesothelioma; Neoplasm, Residual; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Prodrugs; Second-Look Surgery	2007
Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:10 Topics: Antineoplastic Agents; Camptothecin; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Clinical Trials as Topic; Female; France; Humans; Hyperthermia, Induced; Irinotecan; Male; Mesothelioma; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Prodrugs; Prognosis; Prospective Studies; Retrospective Studies	2007
In vitro sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents. Anti-cancer drugs, 2000, Volume: 11, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Transformed; Cell Survival; Comet Assay; Deoxycytidine; DNA Damage; Docetaxel; Epithelial Cells; Gemcitabine; Humans; Irinotecan; Mesothelioma; Paclitaxel; Taxoids; Topoisomerase I Inhibitors; Tumor Cells, Cultured	2000
New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production. Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:6 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; Cell Line; Deoxycytidine; Enzyme-Linked Immunosorbent Assay; Gemcitabine; Humans; Interleukin-6; Irinotecan; Mesothelioma	2000